Séminiaure Télévie 2022

Catégorie
Seminars and symposia
Dates
2022-04-08 08:30 - 16:00
Lieu
ULiège

TELEVIE SEMINAR
April 8th, 2022
ULiège, Amphithéâtre de l’Europe

 


08.30 Welcome and poster set up


09.00 Opening by Prof. Fabrice BUREAU, Vice-Rector of Research ULiège


09.15 Doctoral School of Experimental Cancerology by Prof. Agnès NOËL


SESSION 1 - CANCER METABOLISM
Moderators: Nor Eddine Sounni (ULiège) and Pierre Sonveaux (UCLouvain)


09.30 Preclinical prevention of breast cancer recurrence and metastasis Prof. Pierre SONVEAUX (UCLouvain)
09.55 How do mitochondria regulate endosomal maturation? Dr. Stéphanie HERKENNE (ULiège)

10.20 My research in 180 seconds submitted by 8 Televie PhD students/post-docs
•Marie ANCION – ULiège
•Nicolas HUYGHE – UCLouvain
•Ilaria SALVATO – LIH
•Ophélie DELCORTE – UCLouvain
•Dan GEELEN – UCLouvain
•Sophie PIRENNE – UCLouvain
•Jelena GABRILO – ULB
•Natasha HONORE – UCLouvain

10.50 Coffee break and poster visit

SESSION 2 – MICROBIOME AND CANCER DEVELOPMENT/THERAPY
Moderators: Michael Herfs (ULiège) and Anne Van den Broeke (ULB)


11.30 Microbiota, cancer and cachexia Prof. Laure BINDELS (UCLouvain)
11.55 Interplay between carcinogenic HPV infections and the vaginal microbiome Dr. Michael HERFS (ULiège)

12.20 My research in 180 seconds submitted by 8 Televie PhD students/post-docs
•Ma HAILI - ULB
•Monticelli VITTORIO – ULiège
•Estelle PLANT – ULB
•Sylvie VANDE VELDE - ULB
•Julie CREMER – ULiège
•Coline WERY – ULiège
•Nathan DUBOIS – ULB
•Tereza DVORAKOVA – UCLouvain


12.50 Speech by Prof. Pierre WOLPER, President of F.R.S-FNRS – Rector of ULiège


13.00 Lunch and poster visit
Photo session for new Télévie PhD students/post-docs


SESSION 3 – “INCURABLE” CANCER
Moderator : Bernard GALLEZ (UCLouvain) and Agnès NOËL (ULiège)


14.00 Incurable cancers: challenges and hope for 2022 Dr. Joëlle COLLIGNON (ULiège)
14.25 Cancer cell heterogeneity and plasticity: a paradigm shift in Glioblastoma Prof. Simone NICLOU (LIH)
14.50 Novel RAS(ON) compounds overcome adaptive resistance to KRAS G12C inactive state inhibitors in lung adenocarcinoma Dr. Marie-Julie NOKIN (ULiège)
15.15 Mechanisms involved in the development of esophageal metaplasia Dr. Benjamin BECK (ULB)
15.40 Awards and closing by Prof. Arsène BURNY

 
 

Propulsé par iCagenda


Université de Namur    Université Catholique de Louvain    Université libre de Bruxelles    Université de Mons    Université de Liège

Designed by SOCAMI sprl